SHE:300204

1 story mentioning SHE:300204Updated 17d ago

Every FINWIRES story that references SHE:300204, newest first.

Staidson (Beijing) BioPharmaceuticals Receives Local Approval for Drug Name Change

Municipal regulators in Beijing approved Staidson (Beijing) BioPharmaceuticals' (SHE:300204) name change to its drug production license, according to an afterhours filing on Monday in Shenzhen.The company changed the drug name to Bomitai Enzyme Alpha for Injection from STSP-0601 for Injection.

SHE:300204

Track with the FINWIRES app suite

FolioX

Track SHE:300204 in your portfolio

WheelAI

Analyze SHE:300204 options with the wheel strategy

StockInsider

See market sentiment on SHE:300204